- Home
- ATEX vs CYRX Comparison
ATEX vs CYRX Comparison
Compare ATEX & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATEX | CYRX |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.4M | 421.6M |
| IPO Year | 2014 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ATEX | CYRX |
|---|---|---|
| Price | $36.69 | $8.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $50.00 | $12.83 |
| AVG Volume (30 Days) | ★ 509.8K | 308.9K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.85 | 1.68 |
| Revenue | $6,031,000.00 | ★ $228,385,000.00 |
| Revenue This Year | $8.34 | N/A |
| Revenue Next Year | $4.32 | $9.12 |
| P/E Ratio | $9.61 | ★ $4.92 |
| Revenue Growth | ★ 43.90 | N/A |
| 52 Week Low | $17.58 | $4.63 |
| 52 Week High | $39.62 | $11.45 |
Technical Indicators
Market Signals| Indicator | ATEX | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.95 | 41.98 |
| Support Level | $20.12 | $8.16 |
| Resistance Level | N/A | $9.31 |
| Average True Range (ATR) | 2.44 | 0.42 |
| MACD | 0.17 | 0.04 |
| Stochastic Oscillator | 85.47 | 69.51 |
Price Performance
Historical ComparisonAbout ATEX Anterix Inc.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.